In non-small-cell lung carcinoma (NSCLC), cancer metastasis was associated with inactivation of SMAD2-mediated and activation of SMAD3-mediated transcriptional programs [31]. This evidence concerns the gene SMAD2 and non-small cell lung carcinoma.